Galectin-1 is constitutively expressed in immune privileged sites such as the eye (138), testes (139), and placenta (140), and galectin-1 expression by tumor cells has been shown to dampen the anti-tumor effect of infiltrating CD8 T cells (141, 142). The gene discussed is LGALS1; the disease is neoplasm.